Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.34 |
| ▸ | STAT3 | P40763 | 2/20 | 0.34 |
| ▸ | PTPRS | Q13332 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21020301 | 0.90 | KMT2A (0.35) | KMT2ALMNASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL20650808 | 0.85 | KMT2A (0.36) | KMT2ALMNASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL21019980 | 0.85 | KMT2A (0.36) | KMT2ALMNASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL23967908 | 0.84 | PTPN2 (0.37) | KMT2ALMNASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL21020567 | 0.84 | KMT2A (0.35) | KMT2ALMNASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL15852206 | 0.83 | PTPN2 (0.33) | KMT2APTPN2PTPN1STAT3PTPRS | |
| SCHEMBL21021474 | 0.83 | KMT2A (0.34) | KMT2ALMNASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL21021031 | 0.83 | KMT2A (0.34) | KMT2ALMNASMN1; SMN2PTPN2PTPN1 | |
| SCHEMBL20172832 | 0.83 | CEL (0.32) | LMNA | |
| SCHEMBL20650246 | 0.82 | KMT2A (0.41) | KMT2ALMNASMN1; SMN2PTPN2PTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | KMT2A 280/4885LMNA 3923/4885SMN1; SMN2 1116/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.